Institutional investors hold a majority ownership of ABBV through the 70.32% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended September 2013, these large investors purchased a net $17.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 3.1 Million shares of AbbVie Inc
CAPITAL RESEARCH & MANAGEMENT CO... Bought 2.7 Million shares of AbbVie Inc
T. ROWE PRICE ASSOCIATES, INC. Bought 2.1 Million shares of AbbVie Inc